FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978589039> ?p ?o ?g. }

• W1978589039 endingPage "38" @default.
• W1978589039 startingPage "38" @default.
• W1978589039 abstract "Objectives: The most common mobilization regimens for autologous stem cell transplant (ASCT) are granulocyte-colony stimulating factor (G-CSF) alone or in combination with chemotherapy. Chemotherapy plus G-CSF has been shown to mobilize more cells than G-CSF alone but often at the expense of costly side effects. The purpose of this study was to evaluate resource use and cost during mobilization for patients mobilized with chemotherapy plus G-CSF vs. G-CSF alone. Methods: Patients 18 years of age or older with evidence of ASCT between January 1, 2000 and December 31, 2006 were identified from a nationally-representative database of private payer medical and pharmacy claims. Patients had to receive apheresis within 60 days prior to ASCT and have a history of multiple myeloma, non-Hodgkin's lymphoma, or Hodgkin's disease; patients also were required to be continuously enrolled in one health plan for at least 90 days pre-ASCT and have no evidence of a prior ASCT. Using claims data, patients were classified into one of two mobilization regimens: G-CSF alone or chemotherapy with G-CSF. Total resource use and direct medical costs were calculated from the time of administration of the mobilization regimen to the first apheresis day; paid claims were used as a proxy for costs and expressed in 2006 US$. Results: 235 ASCT patients were identified; 172 (73%) were mobilized with G-CSF alone and 63 (27%) with chemotherapy and G-CSF. Total mobilization costs were 27% higher among patients mobilized with chemotherapy versus those mobilized with G-CSF alone ($39,686 vs. $31,251, P = 0.020). Patients mobilized with chemotherapy had higher inpatient hospital costs ($8,225 vs. $5,854, P = 0.056), more use of growth factor ($9,217 vs. $6,948, P = 0.003), and higher pharmacy costs ($5,343 vs. $1,484, P<0.001) than patients mobilized with G-CSF alone. Rituximab comprised 48% of pharmacy costs in the chemotherapy and G-CSF group, while the remaining costs were due to chemotherapy drugs, MESNA, and anti-emetics. Excluding rituximab and G-CSF, patients mobilized with chemotherapy had pharmacy costs that were $1,645 higher than patients mobilized with G-CSF alone. Conclusion: ASCT patients mobilized with chemotherapy had higher total mobilization costs than patients mobilized with G-CSF alone. This significant difference in costs was due to more costly hospitalizations and greater use of G-CSF and other pharmaceuticals in patients mobilized with chemotherapy.Tabled 1Total Mobilization Costs for Chemotherapy and G-CSF vs. G-CSF AloneChemotherapy and G-CSFG-CSF AloneMean (SD)Mean (SD)% DifferenceP-valueTotal Mobilization Costs$39,686 (31,188)$31,251 (31,750)27%0.020Inpatient$8,225 (19,214)$5,854 (18,312)41%0.056Outpatient$16,901 (17,085)$16,965 (19,772)0%0.971Pharmacy$14,560 (12,067)$8,432 (13,502)73%<0.001- G-CSF$9,217 (7,069)$6,948 (10,514)33%0.003- Rituximab$2,547 (6,228)$332 (1,625)667%<0.001- Other retail pharmacy$2,797 (2,923)$1,152 (2,644)143%<0.001 Open table in a new tab" @default.
• W1978589039 created "2016-06-24" @default.
• W1978589039 creator A5040047282 @default.
• W1978589039 creator A5043925265 @default.
• W1978589039 creator A5064184281 @default.
• W1978589039 date "2009-02-01" @default.
• W1978589039 modified "2023-09-25" @default.
• W1978589039 title "Mobilization With Chemotherapy Compared to G-CSF Alone: An Analysis of Resource Use and Cost in Autologous Stem Cell Transplant Patients" @default.
• W1978589039 doi "https://doi.org/10.1016/j.bbmt.2008.12.114" @default.
• W1978589039 hasPublicationYear "2009" @default.
• W1978589039 type Work @default.
• W1978589039 sameAs 1978589039 @default.
• W1978589039 citedByCount "0" @default.
• W1978589039 crossrefType "journal-article" @default.
• W1978589039 hasAuthorship W1978589039A5040047282 @default.
• W1978589039 hasAuthorship W1978589039A5043925265 @default.
• W1978589039 hasAuthorship W1978589039A5064184281 @default.
• W1978589039 hasBestOaLocation W19785890391 @default.
• W1978589039 hasConcept C126322002 @default.
• W1978589039 hasConcept C129470790 @default.
• W1978589039 hasConcept C13373296 @default.
• W1978589039 hasConcept C141071460 @default.
• W1978589039 hasConcept C143998085 @default.
• W1978589039 hasConcept C156708679 @default.
• W1978589039 hasConcept C166957645 @default.
• W1978589039 hasConcept C170493617 @default.
• W1978589039 hasConcept C2776364478 @default.
• W1978589039 hasConcept C2776694085 @default.
• W1978589039 hasConcept C2776738589 @default.
• W1978589039 hasConcept C2777767877 @default.
• W1978589039 hasConcept C2778336483 @default.
• W1978589039 hasConcept C2778828106 @default.
• W1978589039 hasConcept C2779050716 @default.
• W1978589039 hasConcept C2781413609 @default.
• W1978589039 hasConcept C71924100 @default.
• W1978589039 hasConcept C89560881 @default.
• W1978589039 hasConcept C95457728 @default.
• W1978589039 hasConceptScore W1978589039C126322002 @default.
• W1978589039 hasConceptScore W1978589039C129470790 @default.
• W1978589039 hasConceptScore W1978589039C13373296 @default.
• W1978589039 hasConceptScore W1978589039C141071460 @default.
• W1978589039 hasConceptScore W1978589039C143998085 @default.
• W1978589039 hasConceptScore W1978589039C156708679 @default.
• W1978589039 hasConceptScore W1978589039C166957645 @default.
• W1978589039 hasConceptScore W1978589039C170493617 @default.
• W1978589039 hasConceptScore W1978589039C2776364478 @default.
• W1978589039 hasConceptScore W1978589039C2776694085 @default.
• W1978589039 hasConceptScore W1978589039C2776738589 @default.
• W1978589039 hasConceptScore W1978589039C2777767877 @default.
• W1978589039 hasConceptScore W1978589039C2778336483 @default.
• W1978589039 hasConceptScore W1978589039C2778828106 @default.
• W1978589039 hasConceptScore W1978589039C2779050716 @default.
• W1978589039 hasConceptScore W1978589039C2781413609 @default.
• W1978589039 hasConceptScore W1978589039C71924100 @default.
• W1978589039 hasConceptScore W1978589039C89560881 @default.
• W1978589039 hasConceptScore W1978589039C95457728 @default.
• W1978589039 hasIssue "2" @default.
• W1978589039 hasLocation W19785890391 @default.
• W1978589039 hasOpenAccess W1978589039 @default.
• W1978589039 hasPrimaryLocation W19785890391 @default.
• W1978589039 hasRelatedWork W1895328588 @default.
• W1978589039 hasRelatedWork W1968121182 @default.
• W1978589039 hasRelatedWork W2022355235 @default.
• W1978589039 hasRelatedWork W2118666351 @default.
• W1978589039 hasRelatedWork W2358478083 @default.
• W1978589039 hasRelatedWork W2531393228 @default.
• W1978589039 hasRelatedWork W2613364390 @default.
• W1978589039 hasRelatedWork W3211271500 @default.
• W1978589039 hasRelatedWork W4247486082 @default.
• W1978589039 hasRelatedWork W4283314663 @default.
• W1978589039 hasVolume "15" @default.
• W1978589039 isParatext "false" @default.
• W1978589039 isRetracted "false" @default.
• W1978589039 magId "1978589039" @default.
• W1978589039 workType "article" @default.